ConsumerLab.com uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.

About ConsumerLab.com

Posted July 06, 2022

FDA Warns Kratom Companies for Arthritis, Pain Relief Claims & More

On January 30, 2022, the FDA issued warning letters to four sellers of kratom products because they were promoted to treat pain relief, opioid withdrawal, blood sugar control, anxiety, and to treat rheumatoid arthritis.

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at www.consumerlab.com/join/